Regression of Intracranial Meningiomas Following Treatment with Cabozantinib.

Kotecha, Rupesh; Tonse, Raees; Appel, Haley; Odia, Yazmin; Kotecha, Ritesh R; Rabinowits, Guilherme; Mehta, Minesh P

Kotecha, Rupesh; Tonse, Raees; Appel, Haley; Odia, Yazmin; Kotecha, Ritesh R; Rabinowits, Guilherme; Mehta, Minesh P.

Afiliación

Kotecha R; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA.
Tonse R; Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Appel H; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA.
Odia Y; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA.
Kotecha RR; Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Rabinowits G; Department of Neuro Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA.
Mehta MP; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Curr Oncol ; 28(2): 1537-1543, 2021 04 18.

Article en En | MEDLINE | ID: mdl-33919580

Asunto(s)

Neoplasias Meníngeas; Meningioma; Anilidas/uso terapéutico; Humanos; Neoplasias Meníngeas/tratamiento farmacológico; Meningioma/tratamiento farmacológico; Recurrencia Local de Neoplasia; Piridinas

Palabras clave

VEGF; cabozantinib; meningioma; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Meníngeas / Meningioma Límite: Humans Idioma: En Revista: Curr Oncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google